2025-04-06 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Report

**0. Key Figures Summary:**

UNH has significantly outperformed the S&P 500 (VOO) over the given period, with a cumulative return considerably higher than the benchmark. Recent price action shows a short-term decline, but the stock remains above its 20-day and 60-day moving averages.  Indicators like RSI and PPO suggest a relatively strong but not overbought market.  Earnings show strong revenue growth but some EPS volatility.  Profitability margins are robust.

**1. Performance Comparison with S&P 500:**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of products and services.

* **UNH Cumulative Return:** 88.28%
* **VOO (S&P 500) Cumulative Return:** 71.02%
* **Return Difference:** 17.26%
* **Relative Outperformance:** 44.7% (based on provided historical range)


The table below shows the historical Alpha and Beta values for UNH, indicating its performance relative to the market. A beta above 1 suggests higher volatility than the market.  Alpha represents the excess return compared to the market's return, given its beta.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 64.0% | 56.1% | 34.0% | 0.1 | 181.0 |
| 2016-2018  | 55.0% | 63.9% | 38.0% | 0.3 | 207.3 |
| 2017-2019  | 41.0% | 63.9% | 12.0% | 0.3 | 248.8 |
| 2018-2020  | 6.0% | 63.9% | -23.0% | 0.5 | 301.7 |
| 2019-2021  | 74.0% | 17.0% | 0.0% | 0.5 | 438.0 |
| 2020-2022  | 62.0% | 65.5% | 42.0% | 0.5 | 468.4 |
| 2021-2023  | 42.0% | 67.8% | 14.0% | 0.4 | 472.1 |
| 2022-2024  | -35.0% | 68.9% | -50.0% | 0.3 | 460.8 |
| 2023-2025  | -22.0% | 73.5% | -25.0% | 0.1 | 480.3 |


**2. Recent Price Action:**

* **Closing Price:** $525.05
* **Previous Close:** $540.44
* **Change:** -$2.85 (a decrease of 0.53%)
* **5-Day Moving Average:** $527.11
* **20-Day Moving Average:** $508.36
* **60-Day Moving Average:** $510.85

The recent price shows a short-term decline but remains above its key moving averages, suggesting potential support.  The drop of -$2.85 warrants consideration of potential market factors impacting UNH.

**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.4693 (High Risk according to provided scale)
* **RSI:** 68.31 (Approaching overbought territory)
* **PPO:** 0.5755 (Positive, suggesting upward momentum)
* **20-Day Relative Divergence Change:** +19.7% (Short-term upward trend)
* **Expected Return (Long-Term, >2 years):** 36.2% (above S&P 500)

The MRI suggests a higher level of risk.  The positive PPO and the upward trend in relative divergence are bullish signals, but the RSI nearing overbought levels indicates potential for a short-term correction. The high expected return suggests significant long-term potential relative to the S&P 500, despite the near-term risk.


**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue       |
|------------|-------|----------------|
| 2024-11-04 | 6.56  | $100.82 B      |
| 2024-08-09 | 4.58  | $98.86 B      |
| 2024-05-09 | -1.53 | $99.80 B      |
| 2023-11-06 | 6.31  | $92.36 B      |
| 2024-11-04 | 6.31  | $92.36 B      |

Revenue shows consistent growth, while EPS exhibits some volatility, with a notable negative EPS in Q2 2024.  Further investigation into the cause of the Q2 2024 negative EPS is needed for a complete picture. There is a duplicate entry for 2024-11-04; this needs clarification.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue     | Profit Margin |
|---------|-------------|---------------|
| 2024-12-31 | $100.81B   | 21.14%        |
| 2024-09-30 | $100.82B   | 22.84%        |
| 2024-06-30 | $98.86B    | 22.31%        |
| 2024-03-31 | $99.80B    | 23.05%        |
| 2023-12-31 | $94.43B    | 23.30%        |

Revenue remains strong and consistently high. Profit margins are healthy and relatively stable, indicating strong profitability.


**Capital and Profitability:**

| Quarter | Equity      | ROE           |
|---------|-------------|---------------|
| 2024-12-31 | $92.66B    | 5.98%         |
| 2024-09-30 | $94.53B    | 6.41%         |
| 2024-06-30 | $89.36B    | 4.72%         |
| 2024-03-31 | $86.69B    | -1.63%        |
| 2023-12-31 | $88.76B    | 6.15%         |

Equity shows some fluctuation but remains high. ROE is generally positive and indicates a good return on investment, although Q1 2024 shows a negative ROE, requiring further analysis.


**6. Overall Analysis:**

UNH has demonstrated strong historical outperformance relative to the S&P 500.  While recent price action shows a short-term decline, the stock remains supported by its moving averages. Indicators suggest a relatively strong but not overbought market.  Earnings show robust revenue growth, but EPS volatility warrants further investigation, particularly the negative EPS in Q2 2024.  The high expected return suggests significant long-term potential, despite the higher-than-average market risk.  A deeper dive into the Q2 2024 earnings and the reasons behind the negative EPS and ROE is recommended.  Further investigation into potential market factors driving the recent price decrease is also crucial for a comprehensive analysis.
